iBio
IBIO
#10072
Rank
C$98.54 M
Marketcap
C$1.98
Share price
2.14%
Change (1 day)
93.98%
Change (1 year)

EPS for iBio (IBIO)

EPS in 2026 (TTM): C-$1.06

According to iBio's latest financial reports the company's current EPS (TTM) is C-$1.04. In 2025 the company made an earnings per share (EPS) of C-$2.43 an increase over its 2024 EPS that were of C-$9.02.

EPS history for iBio from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$1.06-56.13%
2025C-$2.43-73.08%
2024C-$9.02-93.88%
2023C-$147.31-8.14%
2022C-$160.3692.67%
2021C-$83.23-80.33%
2020C-$423.10-35.11%
2019C-$651.98-38.96%
2018C-$1,068-6.1%
2017C-$1,13836.67%
2016C-$832.3233.33%
2015C-$624.2450%
2014C-$416.16-53.85%
2013C-$901.68-7.14%
2012C-$971.04-64.1%
2011C-$2,70577.27%
2010C-$1,526144.44%
2009C-$624.2412.93%
2008C-$552.7812.2%
2007C-$492.67

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$12.12-1,264.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
C-$0.72-30.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
C-$11.68 1,022.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C-$0.24-77.33%๐Ÿ‡บ๐Ÿ‡ธ USA